Valuation: BioNTech SE

Market Cap 2TCr 2.28TCr 1.85TCr 1.7TCr 3.21TCr 2,19500Cr 3.27TCr 22TCr 8.63TCr 1,07100Cr 8.57TCr 8.38TCr 3,70100Cr P/E 2026 *
-18x
P/E 2027 * -17.7x
Enterprise Value 912.36Cr 1.04TCr 843.38Cr 778.05Cr 1.46TCr 1,00300Cr 1.49TCr 10TCr 3.94TCr 49TCr 3.91TCr 3.83TCr 1,69000Cr EV / Sales 2026 *
4.21x
EV / Sales 2027 * 4.79x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+0.37%
1 week-4.13%
Current month-2.85%
1 month-0.15%
3 months-8.14%
6 months-17.16%
Current year-5.04%
1 week 88.35
Extreme 88.35
94.62
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Executive Officer 60 02/06/2008
Chief Tech/Sci/R&D Officer 59 01/01/2018
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Director/Board Member 72 01/01/2022
Director/Board Member 69 02/06/2008
Director/Board Member 65 15/05/2026
Date Insider Type Main position Quantity % Market Cap.
12/05Free

General Counsel

22,655 0.0094%
12/05Free

Chief Operating Officer

22,655 0.0094%
12/05Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-4.13%-18.56%-16.48% 2.28TCr
+6.05%+7.79%+62.23%+88.46% 5.35TCr
+0.21%-6.28%+56.18%+127.90% 5.42TCr
+0.89%-2.42%+8.07%+434.51% 2.37TCr
+2.36%+3.86%+42.80%-6.60% 1.95TCr
-2.29%-1.92%+35.57%-29.14% 1.78TCr
-4.00%-10.96%+181.91%+328.17% 1.6TCr
-1.15%-3.07%+45.33%+654.85% 1.54TCr
-0.48%-2.30%+22.36%+187.62% 1.41TCr
+1.10%-1.56%+67.84%+137.79% 1.22TCr
Average +0.31%-1.29%+50.37%+190.71% 2.49TCr
Weighted average by Cap. +1.18%-0.42%+49.63%+162.79%

Financials

2026 *2027 *
Net sales 216.79Cr 247.58Cr 200.41Cr 184.88Cr 348.09Cr 24TCr 355.06Cr 2.39TCr 936.9Cr 12TCr 929.88Cr 909.06Cr 40TCr 223.07Cr 254.76Cr 206.21Cr 190.24Cr 358.17Cr 25TCr 365.35Cr 2.46TCr 964.04Cr 12TCr 956.81Cr 935.4Cr 41TCr
Net income -104.89Cr -119.78Cr -97Cr -89Cr -168.41Cr -12TCr -171.78Cr -1.16TCr -453.29Cr -5.62TCr -449.89Cr -439.82Cr -19TCr -116.46Cr -133Cr -107.66Cr -99Cr -187Cr -13TCr -190.74Cr -1.28TCr -503.32Cr -6.25TCr -499.54Cr -488.36Cr -22TCr
Net Debt -1.09TCr -1.24TCr -1TCr -925.65Cr -1.74TCr -1,19300Cr -1.78TCr -12TCr -4.69TCr -58TCr -4.66TCr -4.55TCr -2,01100Cr -928.56Cr -1.06TCr -858.36Cr -791.87Cr -1.49TCr -1,02000Cr -1.52TCr -10TCr -4.01TCr -50TCr -3.98TCr -3.89TCr -1,72000Cr
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
14/26/14 $90.40 +0.37% 9,22,784
13/26/13 $90.07 -1.55% 6,71,508
10/26/10 $91.49 -1.60% 5,51,755
09/26/09 $92.98 -0.59% 8,16,162
08/26/08 $93.53 -0.81% 6,86,516
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
79.00EUR
Average target price
106.79EUR
Spread / Average Target
+35.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock